Latest Breaking News On - Yujin hoshida - Page 1 : vimarsana.com

Combined therapy makes headway for liver cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without

Combined therapy makes headway for liver cancer

A drug that targets a protein known as phosphatidylserine boosted the response rate for hepatocellular carcinoma (HCC) patients receiving immunotherapy without

UT Southwestern immunologists uncover obesity-linked trigger to severe form of liver disease

UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and po

Discovery could pave the way for developing therapies to treat nonalcoholic steatohepatitis

UT Southwestern immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of nonalcoholic fatty liver disease and potential liver failure.

Discovery could pave way for development of therapies to treat non-alcoholic steatohepatitis

Study Points Toward New Ways to Prevent Liver Cancer

Blood test developed to predict liver cancer risk

Simple blood test can predict liver cancer risk in NAFLD patients

An estimated one-quarter of adults in the U.S. have nonalcoholic fatty liver disease (NAFLD), an excess of fat in liver cells that can cause chronic inflammation and liver damage, increasing the risk of liver cancer.

UTSW researchers develop blood test to predict liver cancer risk

Protein levels in blood samples of patients with nonalcoholic fatty liver disease reveal those at highest risk who should be screened regularly for liver cancer.

Biosignatures Show Potential For Predicting Cancer Risk in Non-Alcoholic Liver Disease Patients

Tissue gene expression and blood serum protein signatures distinguished between NAFLD patients with higher or lower risk of hepatocellular carcinoma development or recurrence.